Adaptive Designs in Clinical Trials 2018
In its 10th year, the Adaptive Designs in Clinical Trials conference returns to central London in April 2018...
List view / Grid view
In its 10th year, the Adaptive Designs in Clinical Trials conference returns to central London in April 2018...
Scientists have discovered a way to rein in an overactive protein that drives some aggressive leukaemias...
Genome editing could enable new strategies to prevent malaria transmission to humans...
Doctors may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan.
Individuals who release low numbers of schistosome eggs in their faeces may now use the Helmintex method-- which uses a magnetic field to isolate eggs to detect infections...
Study of Drosophila links ceramide accumulation to heart dysfunction...
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
Scientists in Switzerland have developed a new means of crystallising membrane proteins – a hitherto elusive feat – in order to study their structure and aid understanding of their processes.
Biophysicists in Russia have gained greater understanding about the structure of nanofibrous scaffolds – termed nanoscaffolds – in a study that is researching heart tissue regeneration.
Researchers have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 protects mice and rats from noise- or drug-induced hearing loss...
Researchers have discovered that the EGFL7 protein inhibits the migration of immune cells into the brain...
Research shows that preventing or reversing ‘T-cell exhaustion’ with targeted therapies could enhance the effects of immunotherapy.
When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children...
Researchers report a method for identifying splicing-based biomarkers for hepatocellular carcinoma....
Researchers in Spain have identified a function of the MT4-MMP protease (an enzyme that breaks down proteins) that could be targeted as a potential treatment for some infections, as well as tumour metastasis.